C

Clearmind Medicine Inc
CNSX:CMND

Watchlist Manager
Clearmind Medicine Inc
CNSX:CMND
Watchlist
Price: 1.6 CAD -12.57% Market Closed
Market Cap: 5.1m CAD

Clearmind Medicine Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Clearmind Medicine Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
C
Clearmind Medicine Inc
CNSX:CMND
EPS (Diluted)
-$42
CAGR 3-Years
-65%
CAGR 5-Years
-135%
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
-123%
CAGR 10-Years
N/A
Cardiol Therapeutics Inc
TSX:CRDL
EPS (Diluted)
CA$0
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
EPS (Diluted)
-$1
CAGR 3-Years
-43%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Willow Biosciences Inc
TSX:WLLW
EPS (Diluted)
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
45%
CAGR 10-Years
N/A
No Stocks Found

Clearmind Medicine Inc
Glance View

Market Cap
5.1m CAD
Industry
N/A

Clearmind Medicine, Inc. operates as a mineral resource company, which acquires, explores, develops, and operates mineral resource assets in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-15. The firm is focused on the discovery and development of novel psychedelic derived therapeutics to solve health problems including alcohol use disorder. The firm is engaged in the research and development of compounds derived from psychedelics and commercializes them as regulated medicines, foods, or supplements. The firm's portfolio consists of patent families such as binge behavior regulators and alcoholic beverage substitutes.

CMND Intrinsic Value
Not Available
C

See Also

What is Clearmind Medicine Inc's EPS (Diluted)?
EPS (Diluted)
-42.6 USD

Based on the financial report for Oct 31, 2023, Clearmind Medicine Inc's EPS (Diluted) amounts to -42.6 USD.

What is Clearmind Medicine Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-135%

Over the last year, the EPS (Diluted) growth was 73%. The average annual EPS (Diluted) growth rates for Clearmind Medicine Inc have been -65% over the past three years , -135% over the past five years .

Back to Top